Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
+$1.41B |
| 2 |
Eli Lilly
LLY
|
+$945M |
| 3 |
Exxon Mobil
XOM
|
+$890M |
| 4 |
RTX Corp
RTX
|
+$675M |
| 5 |
Verizon
VZ
|
+$660M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
+$1.81B |
| 2 |
Deutsche Bank
DB
|
+$1.49B |
| 3 |
Amgen
AMGN
|
+$1.06B |
| 4 |
Charles Schwab
SCHW
|
+$1.02B |
| 5 |
Broadcom
AVGO
|
+$965M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Healthcare | 16.3% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Industrials | 10.89% |
| 5 | Financials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Weatherford International
WFRD
$4.48B
| $99.5M | 0.03% |
4,697,823
-28,424
| -0.6% | -$602K |
|
277
Globus Medical
GMED
$7.93B
| $99.4M | 0.03% |
1,770,315
-130,799
| -7% | -$7.34M |
|
278
Freshpet
FRPT
$2.67B
| $97.4M | 0.03% |
1,877,615
-1,273,931
| -40% | -$66.1M |
|
279
Chegg
CHGG
$167M
| $97.2M | 0.03% |
5,177,591
+1,012,561
| +24% | +$19M |
|
280
Credo Technology Group
CRDO
$28B
| $96.1M | 0.03% |
8,750,082
| – | – |
|
281
US Bancorp
USB
$76.5B
| $92.3M | 0.03% |
2,005,972
-3,414,323
| -63% | -$157M |
|
282
TPG
TPG
$9.05B
| $90.7M | 0.03% |
3,791,621
+1,683
| +0% | +$40.2K |
|
283
International Flavors & Fragrances
IFF
$16.8B
| $90.1M | 0.03% |
+756,732
| New | +$90.1M |
|
284
XP
XP
$9.94B
| $89.7M | 0.03% |
4,993,472
-9,859,394
| -66% | -$177M |
|
285
CCC Intelligent Solutions
CCCS
$6.37B
| $89.1M | 0.03% |
9,683,540
+1,632
| +0% | +$15K |
|
286
Extra Space Storage
EXR
$31.2B
| $88.9M | 0.03% |
+522,382
| New | +$88.9M |
|
287
Petrobras
PBR
$81.4B
| $87.9M | 0.03% |
7,527,433
-20,783,512
| -73% | -$243M |
|
288
Restaurant Brands International
QSR
$20.6B
| $87.3M | 0.03% |
+1,741,569
| New | +$87.3M |
|
289
Guardant Health
GH
$6.85B
| $86.7M | 0.03% |
2,149,333
-1,860,172
| -46% | -$75M |
|
|
SBNY
290
DELISTED
Signature Bank
SBNY
| $84.9M | 0.03% |
473,860
+113,948
| +32% | +$20.4M |
|
291
Golden Entertainment
GDEN
$638M
| $84.3M | 0.03% |
2,131,300
+65,200
| +3% | +$2.58M |
|
292
Willis Towers Watson
WTW
$33B
| $83.7M | 0.03% |
424,248
| – | – |
|
293
Trane Technologies
TT
$89.2B
| $83.5M | 0.03% |
+642,608
| New | +$83.5M |
|
294
Novartis
NVS
$240B
| $83.2M | 0.03% |
984,751
-363
| -0% | -$30.7K |
|
295
Skechers
SKX
| $80.1M | 0.02% |
2,250,000
+50,000
| +2% | +$1.78M |
|
296
NCR Voyix
VYX
$1.77B
| $79.3M | 0.02% |
4,155,278
+163,163
| +4% | +$3.11M |
|
297
Coupang
CPNG
$59.1B
| $79M | 0.02% |
6,192,805
+793,898
| +15% | +$10.1M |
|
298
Extreme Networks
EXTR
$2.95B
| $77.7M | 0.02% |
8,705,375
-2,350,000
| -21% | -$21M |
|
299
Chart Industries
GTLS
$8.95B
| $75.2M | 0.02% |
449,280
+194,280
| +76% | +$32.5M |
|
300
Coursera
COUR
$1.8B
| $69.5M | 0.02% |
4,902,442
-2,350,656
| -32% | -$33.3M |
|